| Ident. | Authors (with country if any) | Title |
|---|
| 000077 (2021) |
Muhammad Sani Ismaila [Trinité-et-Tobago] ; Faruku Bande [Nigeria] ; Aminu Ishaka [Nigeria] ; Aminatu Abubakar Sani [Nigeria] ; Karla Georges [Trinité-et-Tobago] | Therapeutic options for COVID-19: a quick review. |
| 000107 (2021) |
O O Oleribe [Nigeria] ; P. Oskouipour [États-Unis] ; O. Nwanyanwu [États-Unis] ; S D Taylor-Robinson [Royaume-Uni] | The COVID-19 era: the view from Nigeria. |
| 000175 (2021) |
Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa | SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. |
| 000271 (2021) |
Ahmed A. Ishola [Nigeria] ; Kayode E. Adewole [Nigeria] ; Habibu Tijjani [Nigeria] ; Suliat I. Abdulai [Nigeria] ; Nnaemeka T. Asogwa [Nigeria] | Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs. |
| 000331 (2021) |
Haruna Isiyaku Umar [Nigeria, Inde] ; Bushra Siraj [Inde, Pakistan] ; Adeola Ajayi [Nigeria] ; Tajudeen O. Jimoh [Thaïlande, Ouganda] ; Prosper Obed Chukwuemeka [Nigeria] | Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus. |
| 000349 (2021) |
Gaber El-Saber Batiha [Égypte] ; Marwa A. Zayed [Égypte] ; Aya A. Awad [Égypte] ; Hazem M. Shaheen [Égypte] ; Suleiman Mustapha [Nigeria] ; Oscar Herrera-Calderon [Pérou] ; Jorge Pamplona Pagnossa [Brésil] ; Abdelazeem M. Algammal [Égypte] ; Muhammad Zahoor [Pakistan] ; Achyut Adhikari [Népal] ; Ishan Pandey [Inde] ; Sara T. Elazab [Égypte] ; Kannan R R. Rengasamy [Afrique du Sud] ; Natália Cruz-Martins [Portugal] ; Helal F. Hetta [Égypte] | Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. |
| 000383 (2021) |
Haruna I. Umar [Nigeria] ; Sunday S. Josiah [Nigeria] ; Tolulope P. Saliu [Nigeria] ; Tajudeen O. Jimoh [Thaïlande] ; Adeola Ajayi [Nigeria] ; Jamilu B. Danjuma [Nigeria] | In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants. |
| 000406 (2021) |
Pathum Sookaromdee [Thaïlande] ; Viroj Wiwanitkit [Nigeria] | Hydroxychloroquine, TTP, COVID-19, and SLE |
| 000519 (2021) |
Zakariya Kashour [Canada] ; Muhammad Riaz [Pakistan] ; Musa A. Garbati [Nigeria] ; Oweida Aldosary [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite] ; Dana Gerberi [États-Unis] ; M Hassan Murad [États-Unis] ; M Rizwan Sohail [États-Unis] ; Tarek Kashour [Arabie saoudite] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis] | Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. |
| 000523 (2021) |
Paul Eze [États-Unis] ; Kenechukwu N. Mezue [États-Unis] ; Chidozie U. Nduka [Royaume-Uni] ; Ijeoma Obianyo [Nigeria] ; Obiora Egbuche [États-Unis] | Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials. |
| 000656 (2021) |
Imad M. Tleyjeh [Arabie saoudite, États-Unis] ; Zakariya Kashour [Canada] ; Oweida Aldosary [Arabie saoudite] ; Muhammad Riaz [Pakistan] ; Haytham Tlayjeh [Arabie saoudite] ; Musa A. Garbati [Nigeria] ; Rana Tleyjeh [Arabie saoudite] ; Mouaz H. Al-Mallah [États-Unis] ; M Rizwan Sohail [États-Unis] ; Dana Gerberi [États-Unis] ; Aref A. Bin Abdulhak [États-Unis] ; John R. Giudicessi [États-Unis] ; Michael J. Ackerman [États-Unis] ; Tarek Kashour [Arabie saoudite] | Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. |
| 000815 (2020) |
Aimé Bonny [Cameroun] ; Mohammed A. Talle [Nigeria] ; Marcus Ngantcha [Cameroun] ; Muzahir H. Tayebjee [Royaume-Uni] | Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000869 (2020) |
Viroj Wiwanitkit [Inde, République populaire de Chine, Nigeria, Serbie] | Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19. |
| 000B78 (2020) |
Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Brian Godman [Royaume-Uni] ; Santosh Kumar [Inde] ; Salequl Islam [Bangladesh] ; Iffat Jahan [Bangladesh] ; Mainul Haque [Malaisie] | Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications. |
| 000D70 (2020) |
Israel Abebrese Sefah [Ghana] ; Olayinka O. Ogunleye [Nigeria] ; Darius Obeng Essah [Ghana] ; Sylvia A. Opanga [Kenya] ; Nadia Butt [Kenya] ; Annie Wamaitha [Kenya] ; Anastasia Nkatha Guantai [Kenya] ; Ibrahim Chikowe [Malawi] ; Felix Khuluza [Malawi] ; Dan Kibuule [Namibie] ; Lahya Nambahu [Namibie] ; Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Zikria Saleem [Pakistan] ; Aubrey C. Kalungia [Zambie] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Santosh Kumar [Inde] ; Jacqueline Sneddon [Royaume-Uni] ; Joshua Wamboga [Ouganda] ; Janney Wale [Australie] ; Nenad Miljkovi [Serbie] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Antony P. Martin [Royaume-Uni] ; Brian Godman [Royaume-Uni, Afrique du Sud, Malaisie, Suède] | Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. |
| 000F39 (2020) |
Joyce Oloaigbe Ogidigo [Nigeria] ; Emmanuel A. Iwuchukwu [Afrique du Sud] ; Collins U. Ibeji [Afrique du Sud, Nigeria] ; Okiemute Okpalefe [Nigeria] ; Mahmoud E S. Soliman [Afrique du Sud] | Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach. |
| 000F62 (2020) |
Yusuf Muhammed [Nigeria] | Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment. |
| 001631 (2020) |
Pascale M. Abena [Cameroun] ; Eric H. Decloedt [Afrique du Sud] ; Emmanuel Bottieau [Belgique] ; Fatima Suleman [Afrique du Sud] ; Prisca Adejumo [Nigeria] ; Nadia A. Sam-Agudu [Ghana, Nigeria, États-Unis] ; Jean-Jacques Muyembe Tamfum ; Moussa Seydi [Sénégal] ; Serge P. Eholie [Côte d'Ivoire] ; Edward J. Mills [Rwanda] ; Oscar Kallay [Belgique] ; Alimuddin Zumla [Royaume-Uni] ; Jean B. Nachega [Afrique du Sud, États-Unis] | Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings. |
| 001788 (2020) |
Richard Oluyinka Akintayo ; Akpabio Akpabio [Nigeria] ; Asgar Kalla [Afrique du Sud] ; Dzifa Dey [Ghana] ; Angela Migowa [Kenya] ; Hakeem Olaosebikan [Nigeria] ; Rachid Bahiri [Maroc] ; Yasser El Miedany [Égypte] ; Djohra Hadef [Algérie] ; Wafa Hamdi [Tunisie] ; Omondi Oyoo [Kenya] ; Samy Slimani [Algérie] ; Abubakar Yerima [Nigeria] ; Yassmin Taha [Soudan] ; Adewale Adebajo [Royaume-Uni] ; Olufemi Adelowo [Nigeria] ; Mohammed Tikly [Afrique du Sud] ; Imad Ghozlani [Maroc] ; Kawther Ben Abdelghani [Tunisie] ; Nermeen Ahmed Fouad [Égypte] ; Doaa Mosad [Égypte] ; Dalia El Mikkawy [Égypte] ; Mohamed Hassan Abu-Zaid [Égypte] ; Rasha A. Abdel-Magied [Égypte] | COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic. |
| 001928 (2020) |
Richard Oluyinka Akintayo [Royaume-Uni] ; Rachid Bahiri [Maroc] ; Yasser El Miedany [Égypte] ; Hakeem Olaosebikan [Nigeria] ; Asgar Ali Kalla [Afrique du Sud] ; Adewale Olukayode Adebajo [Royaume-Uni] ; Angela Nyangore Migowa [Kenya] ; Samy Slimani [Algérie] ; Ouma Devi Koussougbo ; Ben Abdelghani Kawther [Tunisie] ; Akpabio Akanimo Akpabio [Nigeria] ; Imad Ghozlani [Maroc] ; Dzifa Dey [Ghana] ; Waleed A. Hassan [Égypte] ; Nimmisha Govind [Afrique du Sud] ; Kavita Makan [Afrique du Sud] ; Abdelgaffar Mohamed [Arabie saoudite] ; Eugene Kalman Genga [Kenya] ; Mohamed Khattry Ahmed Ghassem [Maroc] ; Mohamed Mortada [Égypte] ; Wafa Hamdi [Tunisie] ; Moudjib O. Wabi [Bénin] ; Mohammed Tikly [Afrique du Sud] ; Madeleine Ngandeu-Singwe [Cameroun] ; Christian Scott [Afrique du Sud] | African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic. |
